A multicenter characterization of hepatitis associated with immune checkpoint inhibitors

Immune checkpoint inhibitors (ICI) predispose patients to immune-related adverse events (irAEs). Although hepatitis is a potentially lethal toxicity, the timing and outcomes have not been well described. In this retrospective study, patients from six international institutions were included if they...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncoimmunology
Auteurs principaux: Patrinely, J. Randall, McGuigan, Ben, Chandra, Sunandana, Fenton, Sarah E., Chowdhary, Akansha, Kennedy, Lucy B., Mooradian, Meghan J., Palmeri, Marisa, Portal, Daniella, Horst, Sara N., Scoville, Elizabeth A., Long, Georgina V., Shi, Chanjuan, Mehnert, Janice M., Sullivan, Ryan J., Salama, April K., Sosman, Jeffrey A., Menzies, Alexander M., Johnson, Douglas B.
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2021
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889227/
https://ncbi.nlm.nih.gov/pubmed/33628621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1875639
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires